If organizations want to maintain a trustworthy image and connect with their customers, transparency in the pharmaceutical industry needs to become a higher priority. One way to address this situation is to highlight the commitment to ingredient traceability.
Billionaire entrepreneur Mark Cuban – best known as the owner of the Dallas Mavericks and an investor on the ABC business reality series “Shark Tank” – is diving into generic drugs with a new startup, dubbed Mark Cuban Cost Plus Drug Company.
This white paper considers how incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
COVID-19 is many things. It is creating an economic impact like we have never seen before, it’s a lesson in basic hygiene, a test in societal patience, an enormous challenge, and a rare opportunity. It also demonstrates why many have chosen the pharmaceutical profession.
Healthcare practitioners (HCPs) are not only worried about how they will get through COVID-19, but they are also concerned about the long-term well-being of their patients. A new survey published by Fingerpaint, a full-service health and wellness marketing agency, shows that the top concern regarding the pandemic for a majority of HCPs revolves around their patients having access to care – and those concerns are not expected to change for months.
The Bloc’s Dan Sontupe explores why the failure to educate patients about their conditions and treatment plans is a far bigger driver of healthcare costs than the price of prescription drugs.
Even as lawmakers debate and malign proposed plans to lower the costs of prescription drugs in the United States, since the start of 2020, prices increased on more than 600 prescription drugs by an average of 5.2 percent.
In August 1963, the Rev. Martin Luther King delivered his famous “I Have a Dream” speech that called for equality among all people, regardless of their ethnicity, as well as a vision for a better America for all. While the noble dreams that King outlined on that hot day in Washington, D.C. so many years ago have unfortunately not yet been fully realized, there are other kinds of dreams that may be closer to being achieved, particularly in the area of new medications for serious diseases.
Changes in U.S. Food and Drug Administration procedures meant to speed approvals for medications may have resulted in less exacting standards, a new analysis suggests.
Diabetes medications and blood-test supplies are sold, traded and donated on black markets because the U.S. healthcare system is not meeting patients’ needs, a study shows.